Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Retained Earnings (2016 - 2025)

Angiodynamics (ANGO) has disclosed Retained Earnings for 15 consecutive years, with $998000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 100.24% year-over-year to $998000.0, compared with a TTM value of $998000.0 through Nov 2025, up 100.24%, and an annual FY2025 reading of -$2.0 million, up 99.49% over the prior year.
  • Retained Earnings was $998000.0 for Q4 2025 at Angiodynamics, up from -$440.1 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $3.7 million in Q3 2021 and bottomed at -$440.1 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$140.4 million, with a median of -$139.5 million recorded in 2021.
  • The sharpest move saw Retained Earnings skyrocketed 253.96% in 2021, then tumbled 13371.07% in 2025.
  • Year by year, Retained Earnings stood at -$147.2 million in 2021, then fell by 22.23% to -$179.9 million in 2022, then surged by 97.38% to -$4.7 million in 2023, then tumbled by 8794.22% to -$418.7 million in 2024, then soared by 100.24% to $998000.0 in 2025.
  • Business Quant data shows Retained Earnings for ANGO at $998000.0 in Q4 2025, -$440.1 million in Q3 2025, and -$2.0 million in Q2 2025.